jeudi 21 mai 2009

Mesothelioma gene ratio test predicts disease progression post-surgery

"Doctors at the International Mesothelioma Program (IMP) recently completed a study of the effectiveness of a gene ratio test in predicting the course of a patient’s disease after surgery. The gene ratio test was previously developed by physicians at the IMP, a project of Brigham and Women’s Hospital in Boston, Massachusetts.
The study ..."
(2009-5-6)
Read more...